drugset / Trial / NCT02212951

Comparison of Postprandial Glucose Control Associated With BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500

NCT02212951

Phase 1/2 Completed 12 enrolled Biodel
RandomizedCrossoverSingle-blindTreatment

Summary

The study is to compare meal time glucose control associated with BIOD-531, a rapidly absorbed concentrated insulin to that associated with Humalog Mix 75/25 and Humulin R U-500.

Timeline

Start
2014-05
Primary completion
2014-07
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject BIOD-531 Protein / enzyme biologic 0.6 iu/kg Subcutaneous
Comparator Humalog Mix 75/25 Unknown 0.6 iu/kg Subcutaneous
Comparator insulin aspart Protein / enzyme biologic 0.6 iu/kg Subcutaneous